Hemp, CBD investments accelerating in Europe

Cannabidiol investments are heating up across Europe, as entrepreneurs race to capitalize on hemp and CBD business opportunities.

A Swiss cannabis business, CBD420, is marketing hemp strains that meet Europe’s limit of 0.2% THC, with products for sale in more than 1,000 tobacco shops in Switzerland and more than a dozen shops in France, according to The Guardian.

And Canada-based Maricann announced this week that it’s starting a CBD subsidiary in Germany. MariPlant GmbH plans to start selling 25-milligram CBD capsules online in February.

Most European countries consider cannabis below 0.2% THC to be legal hemp.

An exception is Great Britain, where any trace of THC is outlawed. Last year that country’s health agency ruled that any product containing CBD marketed as a medicine must be licensed before it can be sold.

The CEO of CBD420, Jonas Duclos, told The Guardian his company is expanding his low-THC offerings slowly to avoid government crackdowns.

“But the demand is huge,” added Duclos, who plans to expand next to Italy.